The invention relates to recombinantly or synthetically produced HCV E1 envelope proteins or parts thereof comprising disulfides between specific cysteine residues. The initial oxidizing agent can be a non-gaseous composition present in the cathode for immediate availability. The set of records is provided for source verification. An address generator contains an address buffer register which stores a random access address and an address sequencer which provides a stream of addresses to the memory array.